吉野浩代

Yoshino Hiroyo

競争的資金等の研究課題 (3件)：

論文 (100件)：

Kei-Ichi Ishikawa, Ayami Okuzumi, Hiroyo Yoshino, Nobutaka Hattori, Wado Akamatsu. Generation of hiPSCs (JUCGRMi003-A) from a patient with Parkinson's disease with PARK2 mutation. Stem cell research. 2024. 76. 103323-103323
Kei-ichi Ishikawa, Takahiro Shiga, Hiroyo Yoshino, Kenya Nishioka, Nobutaka Hattori, Wado Akamatsu. Generation of three clones (JUCGRMi002-A, B, C) of induced pluripotent stem cells from a Parkinson’s disease patient with SNCA duplication. Stem Cell Research. 2024
Kensuke Daida, Manabu Funayama, Kimberley J Billingsley, Laksh Malik, Abigail Miano-Burkhardt, Hampton L Leonard, Mary B Makarious, Hirotaka Iwaki, Jinhui Ding, J Raphael Gibbs, et al. Long-Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson's Disease. Movement disorders : official journal of the Movement Disorder Society. 2023. 38. 12. 2249-2257
Kensuke Daida, Manabu Funayama, Kimberley J Billingsley, Laksh Malik, Abigail Miano-Burkhardt, Hampton L Leonard, Mary B Makarious, Hirotaka Iwaki, Jinhui Ding, J Raphael Gibbs, et al. Long-read sequencing resolves a complex structural variant in PRKN Parkinson's disease. medRxiv : the preprint server for health sciences. 2023
Toshiki Tezuka, Daisuke Taniguchi, Mariko Sano, Tomoyo Shimada, Yutaka Oji, Taiji Tsunemi, Aya Ikeda, Yuanzhe Li, Hiroyo Yoshino, Jun Ogata, et al. Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson's disease. NPJ Parkinson's disease. 2022. 8. 1. 97-97

MISC (66件)：

吉野浩代, 服部信孝. 【パーキンソン病(第2版)-基礎・臨床研究のアップデート-】病因原因・関連遺伝子 GCH1遺伝子. 日本臨床. 2018. 76. 増刊4 パーキンソン病. 135-139
Nakayama Sachiko, Shimonaka Shotaro, Elahi Montasir, Oji Yutaka, Li Yuanzhe, Hiroyo Yoshino, Nishioka Kenya, Hatano Taku, Motoi Yumiko, Hattori Nobutaka. 新規MAPT遺伝子変異臨床的および生化学的解析(New Mutations in the MAPT Gene: Clinical and Biochemical Characterization). 順天堂醫事雑誌. 2017. 63. 6. 489-490
服部達哉, 服部優子, 後藤洋二, 吉野浩代, 服部信孝. ドーパミントランスポーターSPECT(DAT SPECT)で高度集積低下のみられたbata-propeller protein-associated neurodegeneration(BPAN)の1例. 臨床神経学. 2017. 57. 12. 791-791
西岡健弥, 李元哲, 吉野浩代, 服部信孝. 【神経疾患のゲノム医療】 Parkinson病のゲノム医療. 神経内科. 2017. 86. 6. 660-666
T. Hatano, A. Okuzumi, K. Kamagata, K. Daida, D. Taniguchi, M. Hori, H. Yoshino, S. Aoki, N. Hattori. Neuromelanin imaging is useful for monitoring disease progression in Parkinson's disease and PARK2. MOVEMENT DISORDERS. 2016. 31. S244-S245

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

吉野 浩代